These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond

151
14
Favorite

These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond

Motley Fool2021-09-22

The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

151

Report

Comment（14）

maxwellC
·2021-09-22
Thanks much
Reply
3
Report
HelloKitty55
·2021-09-22
Yes
Reply
3
Report
james_l
·2021-09-22
I like the companies but i am willing to wait and see what happens in rest of september.
Reply
3
Report
Fold Replies
- STKG:
  agree.
  2021-09-22
  Reply
  Report
seojun
·2021-09-22
Thats nice to hear
Reply
2
Report
WCS1981
·2021-09-22
All 3 still abit in the high side
Reply
6
Report
YinnMing
·2021-09-22
Prefer Walt Disney
Reply
6
Report
koolgal
·2021-09-22
Of the 3 I like $Walt Disney(DIS)$ best. Its price just dropped recently and maybe a great time to buy. ?
Reply
18
Report
Fold Replies
- koolgal:
  I agree. Thanks ??
  2021-09-23
  Reply
  Report
- koolgal:
  Yes I agree??
  2021-09-23
  Reply
  Report
- JeremyKok:
  Walt Disney's price is still high. maybe let it drop a bit more?
  2021-09-23
  Reply
  Report
View more 2 comments
BoonHuat
·2021-09-22
Well said.
Reply
5
Report
trojan1337
·2021-09-22
Like pls
Reply
7
Report
Fold Replies
- trojan1337:
  ok
  2021-09-23
  Reply
  Report
- JeremyKok:
  hi. please like and comment back. thank you.
  2021-09-23
  Reply
  Report
- kenong62:
  done
  2021-09-22
  Reply
  Report
beebeeyan
·2021-09-22
ya
Reply
6
Report
Fold Replies
- Foxie:
  Good
  2021-09-22
  Reply
  Report
Joe0319
·2021-09-22
Like me like me
Reply
10
Report
Fold Replies
- Joe0319:
  ok
  2021-09-23
  Reply
  Report
- Joe0319:
  thank u
  2021-09-23
  Reply
  Report
- JeremyKok:
  hi. please like and comment back. thank you.
  2021-09-23
  Reply
  Report
View more 1 comments
glorify
·2021-09-22
Yes! Disney is a long term investment stock. With travel borders opened & more peoplevaccinated, Disney will be a good entertainment for tourists & in turn it will boost the business!???
Reply
13
Report
Fold Replies
- STKG:
  need to wait awhile.
  2021-09-22
  Reply
  Report
- CoolFox:
  Yes it should be a good investment, especially when done with its current dip.
  2021-09-22
  Reply
  Report
- bernardtayet:
  I fully agreed. Will buy in some for investment.
  2021-09-22
  Reply
  Report
闪电侠08
·2021-09-22
Like
Reply
9
Report
Fold Replies
- JeremyKok:
  hi. please like and comment back. thank you.
  2021-09-23
  Reply
  Report
- Ckee:
  Comment here
  2021-09-22
  Reply
  Report
- Anneater:
  K
  2021-09-22
  Reply
  Report
gg123gg
·2021-09-22
Looking forward!
Reply
6
Report
Fold Replies
- SSim:
  Yea
  2021-09-22
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2169397156?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-09-22 11:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2169397156","market":"us","top_or_hot":-1,"title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","media":"Motley Fool","content":"<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRK","symbol_name":"默沙东","start_time":0,"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","article_id":"2169397156","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","pubTimestamp":1632279600,"columns":[],"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRK":"默沙东","DIS":"迪士尼","HD":"家得宝"},"translate_title":"这三只道指股票将在2021年下半年及以后飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DIS":0.9,"HD":0.9,"MRK":0.9},"content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":869415060,"gmtCreate":1632316468750,"gmtModify":1676530750094,"author":{"id":"3567809811257871","authorId":"3567809811257871","name":"maxwellC","avatar":"https://static.tigerbbs.com/e0b21ee5f1d98b50576baf91a3f62784","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3567809811257871","authorIdStr":"3567809811257871"},"htmlText":"Thanks much","listText":"Thanks much","text":"Thanks much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869415060","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":869278748,"gmtCreate":1632298705584,"gmtModify":1676530746224,"author":{"id":"3587095479419511","authorId":"3587095479419511","name":"HelloKitty55","avatar":"https://static.tigerbbs.com/d60ee63e7e29d36d5bc7561ef9bc3ed6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3587095479419511","authorIdStr":"3587095479419511"},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869278748","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":869224643,"gmtCreate":1632296034682,"gmtModify":1676530745473,"author":{"id":"3563436875655076","authorId":"3563436875655076","name":"james_l","avatar":"https://static.tigerbbs.com/7960ea5c640db331ff2de0da32f6a611","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3563436875655076","authorIdStr":"3563436875655076"},"htmlText":"I like the companies but i am willing to wait and see what happens in rest of september.","listText":"I like the companies but i am willing to wait and see what happens in rest of september.","text":"I like the companies but i am willing to wait and see what happens in rest of september.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/869224643","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5958663,"gmtCreate":1632310097866,"gmtModify":1663234271852,"authorId":3586131488444401,"author":{"id":3586131488444401,"idStr":"3586131488444401","authorId":3586131488444401,"name":"STKG","avatar":"https://static.tigerbbs.com/730c2482b43ac1909a601868b378a6e4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869224643,"type":1,"supId":0,"prevId":0,"content":"agree.","text":"agree.","html":"agree."}],"langContent":"EN"},{"id":869221504,"gmtCreate":1632295482708,"gmtModify":1676530745378,"author":{"id":"4087771643270940","authorId":"4087771643270940","name":"seojun","avatar":"https://static.tigerbbs.com/3bd9ce06b0a58d0a81582641f6566970","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4087771643270940","authorIdStr":"4087771643270940"},"htmlText":"Thats nice to hear","listText":"Thats nice to hear","text":"Thats nice to hear","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869221504","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":869295613,"gmtCreate":1632288943932,"gmtModify":1676530744137,"author":{"id":"3582764273979695","authorId":"3582764273979695","name":"WCS1981","avatar":"https://static.tigerbbs.com/f98e28d5b1695429dd1657ecc78f93f5","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3582764273979695","authorIdStr":"3582764273979695"},"htmlText":"All 3 still abit in the high side","listText":"All 3 still abit in the high side","text":"All 3 still abit in the high side","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869295613","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":869296023,"gmtCreate":1632288515762,"gmtModify":1676530744058,"author":{"id":"3586865030350230","authorId":"3586865030350230","name":"YinnMing","avatar":"https://static.tigerbbs.com/0fb5f6208b2090521a6aa4e2013b877e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586865030350230","authorIdStr":"3586865030350230"},"htmlText":"Prefer Walt Disney","listText":"Prefer Walt Disney","text":"Prefer Walt Disney","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869296023","repostId":2169397156,"repostType":2,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":869201105,"gmtCreate":1632287418707,"gmtModify":1676530743806,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"htmlText":"Of the 3 I like&nbsp;<a href=\"https://laohu8.com/S/DIS\">$Walt Disney(DIS)$</a>&nbsp;best.&nbsp; Its price just dropped recently and maybe a great time to buy. ?","listText":"Of the 3 I like&nbsp;<a href=\"https://laohu8.com/S/DIS\">$Walt Disney(DIS)$</a>&nbsp;best.&nbsp; Its price just dropped recently and maybe a great time to buy. ?","text":"Of the 3 I like $Walt Disney(DIS)$ best. Its price just dropped recently and maybe a great time to buy. ?","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":18,"commentSize":10,"repostSize":0,"link":"https://ttm.financial/post/869201105","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5963785,"gmtCreate":1632353463098,"gmtModify":1663234294843,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"currentWearingBadge":{"badgeId":"c4ee29b388ff41cc8462b3b7ea00d1e2-1","templateUuid":"c4ee29b388ff41cc8462b3b7ea00d1e2","name":"Monthly Top Contributor","description":"Top 3 Contributors with the most and best Editor's Picks every month","bigImgUrl":"https://static.tigerbbs.com/b0cad6192443c33dca826a001250fbd4","smallImgUrl":"https://static.tigerbbs.com/5ccd98c646815ce7610b0df338e060cc","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.02","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2003},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.22","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":869201105,"type":1,"supId":5963501,"prevId":0,"content":"I agree.&nbsp; Thanks ??","text":"I agree.&nbsp; Thanks ??","html":"I agree.&nbsp; Thanks ??"},{"id":5962955,"gmtCreate":1632349428655,"gmtModify":1663234291941,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"currentWearingBadge":{"badgeId":"c4ee29b388ff41cc8462b3b7ea00d1e2-1","templateUuid":"c4ee29b388ff41cc8462b3b7ea00d1e2","name":"Monthly Top Contributor","description":"Top 3 Contributors with the most and best Editor's Picks every month","bigImgUrl":"https://static.tigerbbs.com/b0cad6192443c33dca826a001250fbd4","smallImgUrl":"https://static.tigerbbs.com/5ccd98c646815ce7610b0df338e060cc","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.02","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2003},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.22","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":869201105,"type":1,"supId":5959650,"prevId":0,"content":"Yes I agree??","text":"Yes I agree??","html":"Yes I agree??"},{"id":5963501,"gmtCreate":1632352558561,"gmtModify":1663234291256,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869201105,"type":1,"supId":0,"prevId":0,"content":"Walt Disney's price is still high. maybe let it drop a bit more?","text":"Walt Disney's price is still high. maybe let it drop a bit more?","html":"Walt Disney's price is still high. maybe let it drop a bit more?"},{"id":5959650,"gmtCreate":1632316827679,"gmtModify":1663234275528,"authorId":3580979353261795,"author":{"id":3580979353261795,"idStr":"3580979353261795","authorId":3580979353261795,"name":"ToBeRichDad50","avatar":"https://static.tigerbbs.com/a35bb12d4c813bce3738f9c85e2d0d14","vip":1,"crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869201105,"type":1,"supId":0,"prevId":0,"content":"dip more","text":"dip more","html":"dip more"},{"id":5956753,"gmtCreate":1632295492353,"gmtModify":1663234266328,"authorId":4087771643270940,"author":{"id":4087771643270940,"idStr":"4087771643270940","authorId":4087771643270940,"name":"seojun","avatar":"https://static.tigerbbs.com/3bd9ce06b0a58d0a81582641f6566970","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3559581955535845,"repliedAuthor":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"currentWearingBadge":{"badgeId":"c4ee29b388ff41cc8462b3b7ea00d1e2-1","templateUuid":"c4ee29b388ff41cc8462b3b7ea00d1e2","name":"Monthly Top Contributor","description":"Top 3 Contributors with the most and best Editor's Picks every month","bigImgUrl":"https://static.tigerbbs.com/b0cad6192443c33dca826a001250fbd4","smallImgUrl":"https://static.tigerbbs.com/5ccd98c646815ce7610b0df338e060cc","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.02","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2003},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.22","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"objectId":869201105,"type":1,"supId":5956396,"prevId":5956411,"content":"wahhh","text":"wahhh","html":"wahhh"}],"langContent":"EN"},{"id":869676731,"gmtCreate":1632286478323,"gmtModify":1676530743563,"author":{"id":"3574549633778650","authorId":"3574549633778650","name":"BoonHuat","avatar":"https://static.tigerbbs.com/f64154b666040668c472fc3731becde7","vip":1,"crmLevel":7,"crmLevelSwitch":1,"idStr":"3574549633778650","authorIdStr":"3574549633778650"},"htmlText":"Well said.","listText":"Well said.","text":"Well said.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869676731","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":869670438,"gmtCreate":1632285836124,"gmtModify":1676530743454,"author":{"id":"3574916293171379","authorId":"3574916293171379","name":"trojan1337","avatar":"https://static.tigerbbs.com/943a776c7741ee5cc4d67b3592fbb000","vip":1,"hat":"https://static.tigerbbs.com/ae1f49570794979e009a5efdeb6f4789","crmLevel":6,"crmLevelSwitch":1,"idStr":"3574916293171379","authorIdStr":"3574916293171379"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/869670438","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5967730,"gmtCreate":1632368058236,"gmtModify":1663234313437,"authorId":3574916293171379,"author":{"id":3574916293171379,"idStr":"3574916293171379","authorId":3574916293171379,"name":"trojan1337","avatar":"https://static.tigerbbs.com/943a776c7741ee5cc4d67b3592fbb000","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.55%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869670438,"type":1,"supId":5963507,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5963507,"gmtCreate":1632352590106,"gmtModify":1663234294725,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869670438,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."},{"id":5956020,"gmtCreate":1632287227899,"gmtModify":1663234259539,"authorId":3574928367638029,"author":{"id":3574928367638029,"idStr":"3574928367638029","authorId":3574928367638029,"name":"kenong62","avatar":"https://static.tigerbbs.com/37fd00bd8cea11b8aa1aed6d9ddd9413","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869670438,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"EN"},{"id":869647351,"gmtCreate":1632285698073,"gmtModify":1676530743420,"author":{"id":"3581331692871918","authorId":"3581331692871918","name":"beebeeyan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581331692871918","authorIdStr":"3581331692871918"},"htmlText":"ya","listText":"ya","text":"ya","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/869647351","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5956432,"gmtCreate":1632290971566,"gmtModify":1634789330950,"authorId":3572988793196593,"author":{"id":3572988793196593,"idStr":"3572988793196593","authorId":3572988793196593,"name":"Foxie","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869647351,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"}],"langContent":"EN"},{"id":869641244,"gmtCreate":1632285301688,"gmtModify":1676530743282,"author":{"id":"3578544701064972","authorId":"3578544701064972","name":"Joe0319","avatar":"https://static.tigerbbs.com/9b84d55e902f3cdc3167d94be984be1f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3578544701064972","authorIdStr":"3578544701064972"},"htmlText":"Like me like me","listText":"Like me like me","text":"Like me like me","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/869641244","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5971522,"gmtCreate":1632400792099,"gmtModify":1663234333843,"authorId":3578544701064972,"author":{"id":3578544701064972,"idStr":"3578544701064972","authorId":3578544701064972,"name":"Joe0319","avatar":"https://static.tigerbbs.com/9b84d55e902f3cdc3167d94be984be1f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869641244,"type":1,"supId":5963509,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":5963290,"gmtCreate":1632351581479,"gmtModify":1663234291429,"authorId":3578544701064972,"author":{"id":3578544701064972,"idStr":"3578544701064972","authorId":3578544701064972,"name":"Joe0319","avatar":"https://static.tigerbbs.com/9b84d55e902f3cdc3167d94be984be1f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869641244,"type":1,"supId":5955670,"prevId":0,"content":"thank <u>u</u>","text":"thank <u>u</u>","html":"thank <u>u</u>"},{"id":5963509,"gmtCreate":1632352601889,"gmtModify":1663234291426,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869641244,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."},{"id":5955670,"gmtCreate":1632285694435,"gmtModify":1663234256427,"authorId":3581331692871918,"author":{"id":3581331692871918,"idStr":"3581331692871918","authorId":3581331692871918,"name":"beebeeyan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869641244,"type":1,"supId":0,"prevId":0,"content":"o<u><u>h</u></u>","text":"o<u><u>h</u></u>","html":"o<u><u>h</u></u>"}],"langContent":"EN"},{"id":869649697,"gmtCreate":1632285068619,"gmtModify":1676530743234,"author":{"id":"4087698744325360","authorId":"4087698744325360","name":"glorify","avatar":"https://static.tigerbbs.com/bb1a0d88b0029e6cb51d7065d6b143e5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087698744325360","authorIdStr":"4087698744325360"},"htmlText":"Yes! Disney is a long term&nbsp;investment stock. With&nbsp;travel&nbsp;borders opened &amp; more peoplevaccinated, Disney will be a good&nbsp;entertainment for tourists &amp; in&nbsp;turn it will boost the business!???","listText":"Yes! Disney is a long term&nbsp;investment stock. With&nbsp;travel&nbsp;borders opened &amp; more peoplevaccinated, Disney will be a good&nbsp;entertainment for tourists &amp; in&nbsp;turn it will boost the business!???","text":"Yes! Disney is a long term investment stock. With travel borders opened & more peoplevaccinated, Disney will be a good entertainment for tourists & in turn it will boost the business!???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/869649697","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5958668,"gmtCreate":1632310140488,"gmtModify":1663234272150,"authorId":3586131488444401,"author":{"id":3586131488444401,"idStr":"3586131488444401","authorId":3586131488444401,"name":"STKG","avatar":"https://static.tigerbbs.com/730c2482b43ac1909a601868b378a6e4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869649697,"type":1,"supId":0,"prevId":0,"content":"need to wait awhile.","text":"need to wait awhile.","html":"need to wait awhile."},{"id":5955848,"gmtCreate":1632286397241,"gmtModify":1663234259240,"authorId":3584782885850103,"author":{"id":3584782885850103,"idStr":"3584782885850103","authorId":3584782885850103,"name":"CoolFox","avatar":"https://static.tigerbbs.com/53ed2b2a4ca54289d3bee0a3310b5704","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.17","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869649697,"type":1,"supId":0,"prevId":0,"content":"Yes it should be a good investment, especially when done with its current dip.","text":"Yes it should be a good investment, especially when done with its current dip.","html":"Yes it should be a good investment, especially when done with its current dip."},{"id":5956169,"gmtCreate":1632288570732,"gmtModify":1663234256131,"authorId":3583377018896117,"author":{"id":3583377018896117,"idStr":"3583377018896117","authorId":3583377018896117,"name":"bernardtayet","avatar":"https://static.tigerbbs.com/43e8c1fc37a4bff2a94af98953cff267","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.65%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869649697,"type":1,"supId":0,"prevId":0,"content":"I fully agreed. Will buy in some for investment.","text":"I fully agreed. Will buy in some for investment.","html":"I fully agreed. Will buy in some for investment."}],"langContent":"EN"},{"id":869629204,"gmtCreate":1632282340008,"gmtModify":1676530742742,"author":{"id":"3557814871166009","authorId":"3557814871166009","name":"闪电侠08","avatar":"https://static.tigerbbs.com/f6450511f68919f0aaec67826ad592dd","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3557814871166009","authorIdStr":"3557814871166009"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/869629204","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5963517,"gmtCreate":1632352619944,"gmtModify":1663234291350,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869629204,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."},{"id":5955419,"gmtCreate":1632284355775,"gmtModify":1663234257029,"authorId":3579468869888881,"author":{"id":3579468869888881,"idStr":"3579468869888881","authorId":3579468869888881,"name":"Ckee","avatar":"https://static.tigerbbs.com/59c83eb3fca0be8276df2d1f268e7e7e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869629204,"type":1,"supId":0,"prevId":0,"content":"Comment here ","text":"Comment here ","html":"Comment here "},{"id":5955333,"gmtCreate":1632283513246,"gmtModify":1634789434175,"authorId":3581571807225162,"author":{"id":3581571807225162,"idStr":"3581571807225162","authorId":3581571807225162,"name":"Anneater","avatar":"https://static.tigerbbs.com/dd99ef969b35027be1194d21c5482e54","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869629204,"type":1,"supId":0,"prevId":0,"content":"K","text":"K","html":"K"}],"langContent":"EN"},{"id":869662408,"gmtCreate":1632281738804,"gmtModify":1676530742609,"author":{"id":"4088378716140630","authorId":"4088378716140630","name":"gg123gg","avatar":"https://community-static.tradeup.com/news/5a0f75a6bc386ca911f80340ed0a49f1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4088378716140630","authorIdStr":"4088378716140630"},"htmlText":"Looking forward!","listText":"Looking forward!","text":"Looking forward!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/869662408","repostId":2169397156,"repostType":4,"repost":{"id":"2169397156","kind":"highlight","pubTimestamp":1632279600,"share":"https://ttm.financial/m/news/2169397156?lang=&edition=fundamental","pubTime":"2021-09-22 11:00","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2169397156","media":"Motley Fool","summary":"Scoop up these underestimated blue chips while they're not getting much love from the market.","content":"<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.</p>\n<p>That message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst months of the year for stocks -- only adds to the market's woes.</p>\n<p>If you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI).</p>\n<h2>1. Merck &amp; Co.</h2>\n<p>It's interesting. While shares of<b> Merck &amp; Co.</b> (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.</p>\n<p>Lost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.</p>\n<p>Nothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.</p>\n<p>The kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.</p>\n<h2>2. Walt Disney</h2>\n<p>Much like Merck, shares of<b> Walt Disney </b>(NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.</p>\n<p>There may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.</p>\n<p>One hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released <i>Shang-Chi and the Legend of the Ten Rings</i> just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.</p>\n<p>In the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.</p>\n<h2>3. Home Depot</h2>\n<p>Finally, add home improvement retailer <b>The Home Depot</b> (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.</p>\n<p>It's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.</p>\n<p>HD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.</p>\n<p>Then there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.</p>\n<p>Don't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝","MRK":"默沙东","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/09/21/dow-stocks-set-to-soar-2021-2nd-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169397156","content_text":"The current market environment certainly looks less than bullish. Valuations were already stretched thin thanks to the big rally from lows hit in March of last year when the pandemic was starting to spread in earnest. The recent weakness topped off by Monday's meltdown, however, sends a message.\nThat message is: investors are nervous enough to start locking in their profits. The fact that it's September -- typically one of the worst months of the year for stocks -- only adds to the market's woes.\nIf you can look past the present and into the future though, you'll find there are plenty of blue-chip names poised to end the year on a bullish foot and start 2022 with the same momentum. Here's a rundown of three such names that also happen to be components in the Dow Jones Industrial Average (DJINDICES:^DJI).\n1. Merck & Co.\nIt's interesting. While shares of Merck & Co. (NYSE:MRK) participated in the initial rebound rally in March of last year, it dropped out of the effort by April and has been a laggard ever since. In fact, Merck's stock is a mere 14% above its March-2020 low, and down 17% from its pre-pandemic peak. Not being a real contender in the race to create a COVID-19 vaccine only exacerbated investors' disinterest in Merck; the pharmaceutical giant was already out of favor due to the sheer logistical challenges caused by the pandemic itself.\nLost in all the recent noise of the coronavirus contagion, though, is the fact that this is Merck, which still boasts an incredible drug portfolio that includes cancer-fighting drug Keytruda. This drug alone accounted for $14.4 billion of Merck's 2020 revenue of $48 billion, upping the therapy's total sales by 30% year over year. But that's nowhere near the drug's full potential. As more and more uses are identified, some analysts believe Keytruda could produce annualized revenue on the order of $22 billion while other analysts have tossed around a peak-sales figure of $30 billion. It's a stretch goal to be sure, but even if Merck only gets halfway to that target it would still be a big victory.\nNothing about Merck stock's recent performance indicates Keytruda's potential is being factored in. But, as the pandemic fades and allows investors to renew their focus on other matters, Merck shares are in a position to perk up.\nThe kicker: Newcomers will be stepping in while Merck's dividend yield is a healthy 3.6%.\n2. Walt Disney\nMuch like Merck, shares of Walt Disney (NYSE:DIS) have been oddly poor performers of late. While the stock soared over the course of most of last year and into early this year, it's been mostly stagnant since April -- stagnant at a price that's 12% below March's peak. It's arguably one of the market's best reopening plays, but that nuance may also be over-reflected in the stock's 150% rally from last March's low to this March's high.\nThere may be more meat on the bone left to eat, though, so to speak. This Dow component may be ready to rekindle its bullishness as things ease back to normal this year and into the next.\nOne hint of this impending renormalization is the recent decision to stop selling new-release films through Disney+ at the same time they're showing in theaters. The entertainment media giant doesn't need to employ the potentially cannibalistic approach anymore to draw consumers to Disney+, nor does Disney need to worry about wary consumers steering clear of movie theaters. Its recently released Shang-Chi and the Legend of the Ten Rings just broke domestic box office records for a Labor Day weekend, confirming that consumers are ready, willing, and able to visit theaters.\nIn the meantime, while the company's U.S. parks and experiences arm's revenue is only about two-thirds of what it was in 2019 before the pandemic took hold, that's still up from practically nil as of this time last year. Disney's revamped international streaming services are also still relatively nascent in markets like Latin America, India, and different parts of Europe. This sets the stage for unexpected growth sooner rather than later.\n3. Home Depot\nFinally, add home improvement retailer The Home Depot (NYSE:HD) to your list of Dow Jones stocks ready to rally later this year and into 2022.\nIt's another one of those names that soared for the better part of 2020 and through the early part of 2021 only to peter out in recent weeks. Homebuying and remodeling may have been red hot thanks to motivators like low interest rates and people spending more time in their homes. This trend, however, has seemingly run its course.\nHD stock's just been choppy and relatively unproductive since May, with much of that wheel-spinning being the result of slowing growth. While last quarter's sales and earnings both topped estimates, U.S. same-store sales growth of 3.4% for the three-month stretch ending in July loosely implies people have completed all the at-home projects they care to for the time being.\nThen there's the not-so-minor fact that Home Depot shares are priced at more than 22 times this year's projected profits, and almost 22 times 2022's earnings estimates. That sort of pricing doesn't make it feel like there's much room left for more upside.\nDon't be too quick to jump to conclusions about how consumers are feeling and subsequently acting, though. While it was largely buried by other, noisier news, homebuilder confidence moved higher this month -- for the first time in three months -- after reaching a 13-month low in August. Falling materials prices were the prompt for the recovery. In the meantime August's retail sales in the U.S. grew rather than contracting as expected, suggesting consumers are still spending on goods and services outside of the home construction market. The stock's recent lethargy is ultimately a buying opportunity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5955349,"gmtCreate":1632283618454,"gmtModify":1663234258348,"authorId":3573512309350380,"author":{"id":3573512309350380,"idStr":"3573512309350380","authorId":3573512309350380,"name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.10%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":869662408,"type":1,"supId":0,"prevId":0,"content":"Yea","text":"Yea","html":"Yea"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":151,"commentSize":14,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}